Study Highlights Wide Prices Variations In Equivalent Medicine

Pharmaceutical price variations between bioequivalent medicines in Brazil have been identified as vast in many cases, according to a study by the Foundation for Consumer Defence and Protection (Fundação Procon). The data show price variations as high as 1,415% between reference drugs and their generic equivalents, as well as wide differences within their respective groups. BMI believes that the well-publicised results should help further swing market dynamics in favour of generic drugs, while they also highlight the wide levels of discounting below maximum

To read the full article, please choose one of the following options: